[Oral therapy of psoriasis using two vitamin A acid-derivatives (author's transl)].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001799:Blood Sedimentation; D002338:Carotenoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002613:Cheilitis / Q000139:chemically induced; D003967:Diarrhea / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D008055:Lipids; D002338:Carotenoids; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Perorale Applikation zweier Derivate der Vitamin A-Säure zur internen Psoriasis-Therapie. 13-cis-beta-Vitamin A-Säure and Vitamin A-Säure-aethylamid.